OSL — Oncosil Medical Share News
0.000.00%
- AU$22.24m
- AU$15.78m
- AU$1.82m
Brief: Oncosil Medical Receives retirement Notice From Non-Executive Chairman, Otto Buttula
Brief: Oncosil Medical Ltd Says To Streamline Operating Structure
Brief: Oncosil Medical Says Binding Commitment Received From Defender Asset Management
Australia's Oncosil Medical hits record low on discounted entitlement offer
Brief: Oncosil Medical Announces Entitlement Offer To Raise Up To A$9.9 Million
Brief: Oncosil Medical Says Loss For Half-Year Attributable A$5.7 Million
Brief: Oncosil Medical Signs Distribution Agreement For Selected Chinese Markets
Australia's Oncosil Medical jumps on distribution deal
Brief: Oncosil Medical Says Loss For Year Attributable A$10.7 Mln
Australia's Oncosil Medical rises most in nearly 3 months on device insurance
Brief: Oncosil Medical Says Bupa Uk Approves Reimbursement For Oncosil In The Uk-Osl.Ax
Brief: Oncosil Medical Ltd Seeks Trading Halt
Australia's Oncosil Medical falls on discounted placement
Brief: Oncosil Medical Ltd Seeks Trading Halt
Australia's OncoSil Medical rises on nod for cancer device trial in Germany
Brief: Oncosil Medical Says Fully-Funded Trial Approved In Germany
Australia Stock Exchange release from ONCOSIL MEDICAL : Fully-Funded Trial Approved In Germany
Australia Stock Exchange release from ONCOSIL MEDICAL : PRE_NR Ends: 09:59:25
Australia Stock Exchange release from ONCOSIL MEDICAL : Half Yearly Report Results